Glibenclamide Enhances the Therapeutic Benefits of Early Hypothermia after Severe Stroke in Rats

Glibenclamide (GBC) is an antidiabetic drug that is in a class of medications known as sulfonylureas, which play critical roles in attenuating brain edema and reducing mortality in ischemic stroke patients. Therapeutic hypothermia (TH) is another robust neuroprotectant that prevents brain swelling a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Shuzhen, Gao, Xiaoya, Huang, Kaibin, Gu, Yong, Hu, Yafang, Wu, Yongming, Ji, Zhong, Wang, Qing, Pan, Suyue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JKL International LLC 2018
Materias:
Orginal Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065285/
https://www.ncbi.nlm.nih.gov/pubmed/30090656
http://dx.doi.org/10.14336/AD.2017.0927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065285/
https://www.ncbi.nlm.nih.gov/pubmed/30090656
http://dx.doi.org/10.14336/AD.2017.0927

Ejemplares similares